Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) Return on Sales (2016 - 2025)

Historic Return on Sales for iBio (IBIO) over the last 17 years, with Q4 2025 value amounting to 82.46%.

  • iBio's Return on Sales fell 606400.0% to 82.46% in Q4 2025 from the same period last year, while for Dec 2025 it was 82.46%, marking a year-over-year decrease of 466600.0%. This contributed to the annual value of 45.94% for FY2025, which is 38800.0% down from last year.
  • iBio's Return on Sales amounted to 82.46% in Q4 2025, which was down 606400.0% from 57.2% recorded in Q3 2025.
  • In the past 5 years, iBio's Return on Sales registered a high of 3.14% during Q1 2022, and its lowest value of 130.22% during Q4 2023.
  • Moreover, its 5-year median value for Return on Sales was 25.66% (2022), whereas its average is 41.54%.
  • As far as peak fluctuations go, iBio's Return on Sales crashed by -1047200bps in 2023, and later soared by 1084000bps in 2024.
  • Over the past 5 years, iBio's Return on Sales (Quarter) stood at 19.58% in 2021, then crashed by -30bps to 25.5% in 2022, then crashed by -411bps to 130.22% in 2023, then soared by 83bps to 21.82% in 2024, then crashed by -278bps to 82.46% in 2025.
  • Its Return on Sales was 82.46% in Q4 2025, compared to 57.2% in Q3 2025 and 25.82% in Q2 2025.